Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 49 results for "orchid chemicals and pharmaceuticals"

Orchid Chemicals  Pharma Q1 net loss at Rs 47.56 cr
Moneycontrol.com

Orchid Pharma posts net loss at Rs 47.6 crore

Orchid Chemicals and Pharmaceuticals reported a standalone net loss of Rs 47.6 crore for the quarter ended June, against net loss of Rs 60.1 crore for the corresponding period in the previous financial year. Total operating income of the company was ... Business Standard, 2 weeks ago
Orchid Chemicals Pharma Q1 net loss at Rs 47.56 cr Moneycontrol.com, 2 weeks ago
Money Today

Orchid Chemicals gets USFDA nod for anti-bacterial tablets

Press Trust of India | New Delhi June 17, 2015 Last Updated at 18:07 IST Drug firm Orchid Chemicals & Pharmaceuticals has received nod from the US health regulator USFDA for generic anti-bacterial Gemifloxacin Mesylate tablets. The company has received ...
 Business Standard2 months ago Orchid Chemicals geta USFDA approval for Gemifloxacin Mesylate tablets  Money Control2 months ago Orchid Chemicals jumps on getting USFDA nod for anti-bacterial tablets  Business Standard2 months ago Orchid Chem soars 16% on USFDA nod for anti-bacterial tablets  Business Standard2 months ago
[x]  

Orchid Chemicals Pharmaceuticals AGM on Sept 15, 2015

Orchid Chemicals Pharmaceuticals has informed that the 22nd Annual General Meeting (AGM) of the Company will be held on September 15, 2015.
 Money Control1 week ago Orchid Chemicals & Pharmaceuticals to hold AGM  Business Standard1 week ago

PLIGHT OF INDIAN COS

Financial performances of top 100 pharmaceutical companies during 2014-15 indicate the hard times ahead for this once best performing sector of the Indian economy. The key reason for the poor performance of pharmaceutical companies is due to the ...
 PharmaBiz1 month ago Several pharma cos with sharp drop in sales & profits in 5 years dampen investor's mood  PharmaBiz1 month ago Top 100 pharma cos report 1.8% growth in profit, sales grew by 7% during 2014-15  PharmaBiz1 month ago
Sify

Sensex, Nifty flat amid lackluster trades; IT, pharma stocks post smart gains

The market remains quite sluggish this afternoon, with investors largely refraining from making significant moves. Asian markets mostly ended on a positive note, albeit with marginal gains, while European markets are currently trading slightly lower ...
 Sify1 month ago
Money Today

Stocks in focus: Orchid Chem, Cipla and more

BT Online Bureau New Delhi Last Updated: June 18, 2015 | 09:51 IST The BSE Sensex and NSE Nifty opened on a positive note on Thursday tracking the SGX Nifty futures at the Singapore Stock Exchange. At 9.20 am, the BSE Sensex and NSE Nifty were up 0.55 per ...
 Money Today2 months ago

Nicole Williams Sold 973 Shares of Intercept Pharmaceuticals Inc (NASDAQ:ICPT)

Nicole Williams Insider Sell Transaction director, Nicole Williams is the Intercept Pharmaceuticals Inc (NASDAQ:ICPT) 269.31 -2.01 -0.74% s insider that made a sale of shares of Intercept Pharmaceuticals Inc, 973 to be exact. These insider shares ...
 Octafinance1 month ago
Livemint.com

Lupin jumps 8%, most in five years

Mumbai: Shares of Lupin Ltd on Thursday posted their biggest gain in five years after media reports suggesting that the company has secured key drug approvals from US Foods and Drugs Administration (FDA). The stock rose as much as 8.08%—the ...
 Livemint.com1 week ago
Firstpost.com

Forget big disappointments, small-caps surprise investors with up to 25-fold rise in Q1 earnings

As the April-June quarter corporate earnings season nears an end, there is clear disappointment among investors with respect to the earnings of large firms, which continued to post dismal set of numbers, but several small-cap firms emerged as a ...
 Firstpost.com1 week ago
WKRB News

Hospira Receives Average Rating of Hold from Brokerages (NYSE:HSP)

Shares of Hospira (NYSE:HSP) have earned an average recommendation of Hold from the eight brokerages that are covering the stock, Marketbeat reports . Six investment analysts have rated the stock with a hold rating and two have issued a buy rating ...
 WKRB News3 weeks ago Zacks Upgrades Hospira to Buy (HSP)  SleekMoney4 weeks ago Hospira Upgraded to Buy at Zacks (HSP)  WKRB News1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less